30 related articles for article (PubMed ID: 16494006)
1. A Potential Role of CD82/KAI1 during Uterine Decidualization in Mice.
Li Q; Song M; Cao K; Zhang Q
Curr Issues Mol Biol; 2024 Feb; 46(3):1799-1809. PubMed ID: 38534734
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of MACC1, Twist1, and KAI1 expressions in infiltrating urothelial carcinoma of the bladder.
Dai C; Liu Y; Yang R; Zhou L
Int J Clin Exp Pathol; 2019; 12(10):3877-3885. PubMed ID: 31933777
[TBL] [Abstract][Full Text] [Related]
3. The metastasis suppressor CD82/KAI1 regulates cell migration and invasion via inhibiting TGF-β 1/Smad signaling in renal cell carcinoma.
Zhu J; Liang C; Hua Y; Miao C; Zhang J; Xu A; Zhao K; Liu S; Tian Y; Dong H; Zhang C; Li P; Su S; Qin C; Wang Z
Oncotarget; 2017 Aug; 8(31):51559-51568. PubMed ID: 28881668
[TBL] [Abstract][Full Text] [Related]
4. Tetraspanin CD82 Correlates with and May Regulate S100A7 Expression in Oral Cancer.
Reddi KK; Zhang W; Shahrabi-Farahani S; Anderson KM; Liu M; Kakhniashvili D; Wang X; Zhang YH
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473906
[TBL] [Abstract][Full Text] [Related]
5. Targeting CD82/KAI1 for Precision Therapeutics in Surmounting Metastatic Potential in Breast Cancer.
Viera M; Yip GWC; Shen HM; Baeg GH; Bay BH
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503296
[TBL] [Abstract][Full Text] [Related]
6. KAI1(CD82)-DARC(CD234) axis in the stem cell niche.
Hur J; Baek SH; Kim HS
Cell Cycle; 2016 Aug; 15(15):1945-7. PubMed ID: 27163847
[No Abstract] [Full Text] [Related]
7. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma.
Prabhu VV; Devaraj SN
J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339
[TBL] [Abstract][Full Text] [Related]
8. Role of Metastasis Suppressor KAI1/CD82 in Different Cancers.
Yan W; Huang J; Zhang Q; Zhang J
J Oncol; 2021; 2021():9924473. PubMed ID: 34306081
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between the levels of KAI1/CD82 and CD44 and the clinicopathological features of non-small cell lung cancer].
Chen QY; Lin XM; Zhou JY; An Z; Yang L; Jiang ZY
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Feb; 27(2):101-4. PubMed ID: 14990184
[TBL] [Abstract][Full Text] [Related]
10. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.
Yu L; Zhou L; Wu S; Gong X; Feng Z; Ma L; Zhu B; Yao N; Wang D; Dong H
World J Surg Oncol; 2014 Apr; 12():118. PubMed ID: 24758564
[TBL] [Abstract][Full Text] [Related]
12. [Expression of KAI1 gene in human laryngeal carcinoma and its clinical significance].
Bai WL; Ren Z; Pan ZM; Gao H
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):289-91. PubMed ID: 15996322
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical value of KAI1/CD82 in carcinoma of larynx].
Shu Y; Chen H; Tan Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Dec; 19(23):1065-7. PubMed ID: 16494006
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
